Acro Biomedical Co., Ltd. (ACBM) SEC Filing 10-K Annual Report for the fiscal year ending Saturday, December 31, 2022

SEC Filings

ACBM Annual Reports

  • 10-K Annual Report July 2023
  • 10-K Annual Report April 2022
    10-K Annual Report April 2021
    10-K Annual Report January 2020
    10-K Annual Report December 2018
    10-K Annual Report January 2018

Acro Biomedical Co., Ltd.

CIK: 1622996 Ticker: ACBM
Cover - USD ($)
12 Months Ended
Dec. 31, 2022
Jul. 17, 2023
Jun. 30, 2022
Cover [Abstract]   
Entity Registrant NameACRO BIOMEDICAL CO., LTD.  
Entity Central Index Key0001622996  
Document Type10-K  
Amendment Flagfalse  
Entity Voluntary FilersNo  
Current Fiscal Year End Date--12-31  
Entity Well Known Seasoned IssuerNo  
Entity Small Businesstrue  
Entity Shell Companyfalse  
Entity Emerging Growth Companyfalse  
Entity Current Reporting StatusYes  
Document Period End DateDec. 31, 2022  
Entity Filer CategoryNon-accelerated Filer  
Document Fiscal Period FocusFY  
Document Fiscal Year Focus2022  
Entity Common Stock Shares Outstanding 60,042,000 
Entity Public Float  $ 127,678,500
Document Annual Reporttrue  
Document Transition Reportfalse  
Entity File Number000-55643  
Entity Incorporation State Country CodeNV  
Entity Tax Identification Number47-1950356  
Entity Interactive Data CurrentYes  
Entity Address Address Line 112175 Visionary Way  
Entity Address Address Line 2Suite 1160  
Entity Address City Or TownFishers  
Entity Address State Or ProvinceIN  
Entity Address Postal Zip Code46038  
City Area Code317  
Local Phone Number286-6788  
Security 12g TitleCommon Stock, par value $0.001 per share  
Auditor NamePrager Metis CPAs, LLC  
Auditor LocationHackensack, New Jersey  
Auditor Firm Id273  

View differences made from one year to another to evaluate Acro Biomedical Co., Ltd.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ)
Sample 10-K Year-over-Year (YoY) Comparison

Compare this 10-K Annual Report to its predecessor by reading our highlights to see what text and tables were  removed  ,   added    and   changed   by Acro Biomedical Co., Ltd..


Assess how Acro Biomedical Co., Ltd.'s management team is paid from their Annual Proxy

Definitive Proxy Statement (Form DEF 14A)
Screenshot example of actual Proxy Statement

Acro Biomedical Co., Ltd.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2023 10-K Annual Report includes:

  • Voting Procedures
  • Board Members
  • Executive Team
  • Salaries, Bonuses, Perks
  • Peers / Competitors


SEC Filing Tools

Material Contracts, Statements, Certifications & more

Acro Biomedical Co., Ltd. provided additional information to their SEC Filing as exhibits

Ticker: ACBM
CIK: 1622996
Form Type: 10-K Annual Report
Accession Number: 0001640334-23-001347
Submitted to the SEC: Fri Jul 21 2023 12:34:33 PM EST
Accepted by the SEC: Fri Jul 21 2023
Period: Saturday, December 31, 2022
Industry: Amusement And Recreation Services

External Resources:
Stock Quote
Social Media

Bookmark the Permalink: